• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项评价早产儿呼吸窘迫综合征应用半刚性和软性导管行微创表面活性剂给药的初步研究——一项随机对照试验。

A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome-a randomized controlled trial.

机构信息

Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Paracelsus Medical University, Müllner-Haupt-Str. 48, 5020, Salzburg, Austria.

Clinical Research Center Salzburg, Salzburg, Austria.

出版信息

BMC Pediatr. 2022 Nov 4;22(1):637. doi: 10.1186/s12887-022-03714-3.

DOI:10.1186/s12887-022-03714-3
PMID:36333741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9635199/
Abstract

BACKGROUND

In respiratory distress syndrome, many neonatology centers worldwide perform minimal invasive surfactant application in premature infants, using small-diameter catheters for endotracheal intubation and surfactant administration.

METHODS

In this single-center, open-label, randomized-controlled trial, preterm infants requiring surfactant administration after birth, using a standardized minimal invasive protocol, were randomized to two different modes of endotracheal catheterization: Flexible charrière-4 feeding tube inserted using Magill forceps (group 1) and semi-rigid catheter (group 2). Primary outcome was duration of laryngoscopy. Secondary outcomes were complication rate (intraventricular hemorrhage, soft-tissue damage in first week of life) and vital parameters during laryngoscopy. Between 2019 and 2020, 31 infants were included in the study. Prior to in-vivo testing, laryngoscopy durations were studied on a neonatal airway mannequin in students, nurses and doctors.

RESULTS

Mean gestational age and birth weight were 27 + 6/7 weeks and 1009 g; and 28 + 0/7 weeks and 1127 g for group 1 and 2, respectively. Length of laryngoscopy was similar in both groups (61.1 s and 64.9 s) overall (p.77) and adjusted for weight (p.70) or gestational age (p.95). Laryngoscopy failed seven times in group 1 (43.8%) and four times (26.7%) in group 2 (p.46). Longer laryngoscopy was associated with lower oxygen saturation with lowest levels occurring after failed laryngoscopy attempts. Secondary outcomes were similar in both groups. In vitro data on 40 students, 40 nurses and 12 neonatologists showed significant faster laryngoscopy in students and nurses group 2 (p < .0001) unlike in neonatologists (p.13).

CONCLUSION

This study showed no difference in laryngoscopy duration in endotracheal catheterization when comparing semi-rigid and flexible catheters for minimal invasive surfactant application in preterm infants. In accordance with preliminary data and in contrast to published in-vitro trials, experienced neonatologists were able to perform endotracheal catheterization using both semi-rigid and flexible catheters at similar rates and ease, in vitro and in vivo.

TRIAL REGISTRATION

ClinicalTrials.gov. NCT05024435 Registered 27 August 2021-Retrospectively registered.

摘要

背景

在呼吸窘迫综合征中,全球许多新生儿科中心都采用小直径导管对早产儿进行微创表面活性剂应用,以进行气管内插管和表面活性剂给药。

方法

在这项单中心、开放标签、随机对照试验中,使用标准化微创方案后需要进行表面活性剂给药的早产儿,随机分为两种不同的气管内导管插入方式:使用 Magill 夹插入的柔性 Charrière-4 喂养管(第 1 组)和半刚性导管(第 2 组)。主要结局是喉镜检查的持续时间。次要结局是并发症发生率(脑室内出血、生命第一周的软组织损伤)和喉镜检查期间的生命体征。2019 年至 2020 年期间,共有 31 名婴儿纳入研究。在体内测试之前,在学生、护士和医生的新生儿气道模型上研究了喉镜检查持续时间。

结果

第 1 组和第 2 组的平均胎龄和出生体重分别为 27+6/7 周和 1009g;28+0/7 周和 1127g。两组的喉镜检查时间总体上相似(61.1s 和 64.9s;p=0.77),且经体重调整(p=0.70)或胎龄调整(p=0.95)后也相似。第 1 组有 7 次喉镜检查失败(43.8%),第 2 组有 4 次(26.7%)(p=0.46)。较长的喉镜检查时间与较低的氧饱和度相关,最低水平出现在喉镜检查失败后。两组的次要结局相似。在对 40 名学生、40 名护士和 12 名新生儿科医生的体外数据显示,学生和护士组 2 的喉镜检查速度明显快于第 1 组(p<0.0001),而与新生儿科医生不同(p=0.13)。

结论

本研究比较了微创表面活性剂应用中半刚性和柔性导管在早产儿中的气管内插管,结果显示在喉镜检查持续时间方面无差异。与初步数据一致,并与已发表的体外试验相反,经验丰富的新生儿科医生能够以相似的速度和易用性,在体外和体内使用半刚性和柔性导管进行气管内插管。

试验注册

ClinicalTrials.gov。NCT05024435 于 2021 年 8 月 27 日注册-回顾性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea9/9635199/0ed28f09ac05/12887_2022_3714_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea9/9635199/0bcc68a2c4af/12887_2022_3714_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea9/9635199/0ed28f09ac05/12887_2022_3714_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea9/9635199/0bcc68a2c4af/12887_2022_3714_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bea9/9635199/0ed28f09ac05/12887_2022_3714_Fig2_HTML.jpg

相似文献

1
A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome-a randomized controlled trial.一项评价早产儿呼吸窘迫综合征应用半刚性和软性导管行微创表面活性剂给药的初步研究——一项随机对照试验。
BMC Pediatr. 2022 Nov 4;22(1):637. doi: 10.1186/s12887-022-03714-3.
2
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
3
Clinical impact of less invasive surfactant administration using video laryngoscopy in extremely preterm infants.经视频喉镜使用微创肺表面活性物质给药对极早产儿的临床影响。
Pediatr Res. 2023 Mar;93(4):990-995. doi: 10.1038/s41390-022-02197-3. Epub 2022 Jul 19.
4
Surfactant therapy using a bronchofiberscope in respiratory distress syndrome.
Pediatr Int. 2023 Jan;65(1):e15478. doi: 10.1111/ped.15478.
5
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.OPTIMIST - A试验:对妊娠25 - 28周早产儿进行微创表面活性剂治疗的评估。
BMC Pediatr. 2014 Aug 27;14:213. doi: 10.1186/1471-2431-14-213.
6
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.早产儿微创表面活性剂治疗两年后的结局:随机临床试验 OPTIMIST 的随访。
JAMA. 2023 Sep 19;330(11):1054-1063. doi: 10.1001/jama.2023.15694.
7
[Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].[微创肺表面活性物质给药治疗新生儿呼吸窘迫综合征早产儿的疗效:一项多中心临床试验]
Zhonghua Er Ke Za Zhi. 2020 May 2;58(5):374-380. doi: 10.3760/cma.j.cn112140-20191018-00658.
8
Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.经婴儿喂养管给予微创表面活性剂与 InSurE 方法在早产儿中的应用:一项随机对照试验。
Sci Rep. 2022 Dec 19;12(1):21955. doi: 10.1038/s41598-022-23557-3.
9
Experience of less invasive surfactant administration with a 5F infant feeding tube in a tertiary center of low- and middle-income countries.在中低收入国家的三级中心使用 5F 婴儿喂养管进行微创表面活性剂给药的经验。
Pediatr Int. 2023 Jan-Dec;65(1):e15668. doi: 10.1111/ped.15668.
10
Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.避免机械通气的表面活性物质治疗自主呼吸早产儿(AMV):一项开放标签、随机、对照试验。
Lancet. 2011 Nov 5;378(9803):1627-34. doi: 10.1016/S0140-6736(11)60986-0. Epub 2011 Sep 29.

引用本文的文献

1
Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies.采用 LISA-nCPAP 呼吸治疗及辅助围产期策略预防极早早产儿的慢性疾病
Antioxidants (Basel). 2023 May 24;12(6):1149. doi: 10.3390/antiox12061149.

本文引用的文献

1
Surfactant Administration via Thin Catheter: A Practical Guide.经细导管给予表面活性剂:实用指南。
Neonatology. 2019;116(3):211-226. doi: 10.1159/000502610. Epub 2019 Aug 28.
2
Quality assessment and response to less invasive surfactant administration (LISA) without sedation.无镇静条件下的 LISA (经鼻持续气道正压通气)质量评估与处理。
Pediatr Res. 2020 Jan;87(1):125-130. doi: 10.1038/s41390-019-0552-z. Epub 2019 Aug 27.
3
Minimally invasive surfactant therapy failure: risk factors and outcome.微创表面活性剂治疗失败:危险因素和结局。
Arch Dis Child Fetal Neonatal Ed. 2019 Nov;104(6):F636-F642. doi: 10.1136/archdischild-2018-316258. Epub 2019 Apr 29.
4
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update.欧洲呼吸窘迫综合征管理共识指南-2019 更新版。
Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11.
5
Managing neonatal pain in the era of non-invasive respiratory support.管理非侵入性呼吸支持时代的新生儿疼痛。
Semin Fetal Neonatal Med. 2019 Aug;24(4):101004. doi: 10.1016/j.siny.2019.04.004. Epub 2019 Apr 4.
6
Sedation during minimal invasive surfactant therapy: a randomised controlled trial.微创表面活性剂治疗期间的镇静:一项随机对照试验。
Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F378-F383. doi: 10.1136/archdischild-2018-315015. Epub 2018 Aug 1.
7
Administering atropine and ketamine before less invasive surfactant administration resulted in low pain scores in a prospective study of premature neonates.一项针对早产儿的前瞻性研究表明,在给予经鼻持续气道正压通气前给予阿托品和氯胺酮,可降低疼痛评分。
Acta Paediatr. 2018 Jul;107(7):1184-1190. doi: 10.1111/apa.14317. Epub 2018 Apr 16.
8
Five-country manikin study found that neonatologists preferred using the LISAcath rather than the Angiocath for less invasive surfactant administration.一项五国假人研究发现,新生儿科医生更倾向于使用 LISAcath 而非 Angiocath 进行微创肺表面活性剂给药。
Acta Paediatr. 2018 May;107(5):780-783. doi: 10.1111/apa.14214. Epub 2018 Jan 25.
9
Rigid catheters reduced duration of less invasive surfactant therapy procedures in manikins.硬质导管缩短了在人体模型中进行的微创表面活性剂治疗程序的持续时间。
Acta Paediatr. 2017 Jul;106(7):1091-1096. doi: 10.1111/apa.13850. Epub 2017 May 2.
10
European perspective on less invasive surfactant administration-a survey.欧洲对于微创表面活性剂给药的观点——一项调查
Eur J Pediatr. 2017 Feb;176(2):147-154. doi: 10.1007/s00431-016-2812-9. Epub 2016 Dec 9.